<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Quintiles In the News Feed</title><link>http://www.quintiles.com/information-library/in-the-news/</link><description /><language>en-us</language><lastBuildDate>Tue, 29 Jun 2010 15:48:33 -0400</lastBuildDate><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/QuintilesInTheNews" /><feedburner:info uri="quintilesinthenews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item><title>Neupositionierung</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/FChCQIX4hzI/</link><description>Quintiles: Neupositionierung und Integration unter einer internationalen Marke
Ein neuartiger Partner in der sich verändernden Gesundheitslandschaft
Mannheim, 5. Februar 2010 – Quintiles, weltweit führender Outsourcing-Partner der Healthcare Industrie, startet
dieser Tage eine umfassende Kampagne zur Neupositionierung


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/neupositionierung.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/FChCQIX4hzI" height="1" width="1"/&gt;</description><pubDate>Tue, 29 Jun 2010 15:48:33 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/neupositionierung/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/neupositionierung/</feedburner:origLink></item><item><title>Quintiles receives Metastorm partner award</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/KiH4XDFTYYg/</link><description>The consulting group of Quintiles receives the 2010 Metastorm Partner Achievement Award.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/KiH4XDFTYYg" height="1" width="1"/&gt;</description><pubDate>Wed, 02 Jun 2010 15:21:48 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/metastorm-partner-award/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/metastorm-partner-award/</feedburner:origLink></item><item><title>Press Release GPTW-DKD </title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/7sKDf8KoJUY/</link><description>Mannheim, 12. April 2010 – For the 6th time in a row the Mannheim Company Quintiles Commercial Germany GmbH (until January 2010 Innovex GmbH) was awarded as one of the Best Employers in Germany in the Great Place to Work benchmark competition. Practically at the same time the service company won a placement among the 50 best participants in the competition for Germanys Most Customer Oriented Service Companies”. Quintiles supplies the Healthcare Industrie wordwide with Clinical Research, Sales and Marketing as well as Consulting Services and Financial Concepts. Recently Quintiles with its four pillars Clinical, Commercial, Consulting and Capital has announced its new strategy under the tagline “Navitating the New Health”.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/press-release-gptw-dkd-englisch.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/7sKDf8KoJUY" height="1" width="1"/&gt;</description><pubDate>Wed, 26 May 2010 14:06:33 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/press-release-gptw-dkd-englisch/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/press-release-gptw-dkd-englisch/</feedburner:origLink></item><item><title>Press Release GPTW-DKD</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/N_GJ_z-JQds/</link><description>Mannheim, 12. April 2010 – Zum 6. Mal in Folge wurde das Mannheimer Unternehmen Quintiles Commercial Germany GmbH (bis Januar 2010 Innovex GmbH) im Wettbewerb des Great Place to Work Instituts als einer der Besten Arbeitgeber Deutschlands ausgezeichnet. Fast gleichzeitig errang das Unternehmen im Wettbewerb „Deutschlands Kundenorientierteste Dienstleister“ zum 2. Mal in Folge einen Platz unter den besten 50 Teilnehmern. Quintiles bietet der Healthcare Industrie klinische Forschung, Marketing- und Vertrieb, Beratungsleistungen und Finanzierungskonzepte weltweit und aus einer Hand an. Kürzlich hatte Quintiles mit seinen vier Bereichen Clinical, Commercial, Consulting und
Capital seine neue Strategie unter dem Motto „Navigating the New Health“ veröffentlicht.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/press-release-gptw-dkd.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/N_GJ_z-JQds" height="1" width="1"/&gt;</description><pubDate>Wed, 26 May 2010 13:54:20 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/press-release-gptw-dkd/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/press-release-gptw-dkd/</feedburner:origLink></item><item><title>PharmaField awards 2010</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/9HQMnvxtomU/</link><description>Quintles employees take top honours at prestigious PharmaField Awards


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/pharmafield-awards-2010.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/9HQMnvxtomU" height="1" width="1"/&gt;</description><pubDate>Mon, 17 May 2010 10:52:27 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/pharmafield-awards-2010/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/pharmafield-awards-2010/</feedburner:origLink></item><item><title>Pharmaceutical Marketing Europe Article</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/rpWXhxqrdNc/</link><description>Comprehensive product and brand solutions can maximise asset potential in a changing world


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/pharmaceutical-marketing-europe-article.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/rpWXhxqrdNc" height="1" width="1"/&gt;</description><pubDate>Fri, 14 May 2010 09:56:26 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/pharmaceutical-marketing-europe-article/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/pharmaceutical-marketing-europe-article/</feedburner:origLink></item><item><title>PharmAsia News Article Reprint</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/8Z9NDPl5KWc/</link><description>Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/pharmasia-news-article-reprint.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/8Z9NDPl5KWc" height="1" width="1"/&gt;</description><pubDate>Mon, 01 Mar 2010 09:21:33 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/pharmasia-news-article-reprint/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/pharmasia-news-article-reprint/</feedburner:origLink></item><item><title>Associated Press Features Quintiles' Partnering Approach</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/OMW8W3lM0z0/</link><description>Quintiles' approach to increased partnering with customers was profiled in a full-length, national article from the Associated Press which saw publication in many leading news outlets.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/OMW8W3lM0z0" height="1" width="1"/&gt;</description><pubDate>Tue, 16 Feb 2010 15:14:10 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/associated-press-features-quintiles-partnering-approach/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/associated-press-features-quintiles-partnering-approach/</feedburner:origLink></item><item><title>The Value of Reviewing Existing EU Risk Management Plans</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/HGkhFgYo8vg/</link><description>Drug Safety experts Cheryl Key, Barry Mulchrone and Karen Wai describe an electronic database for tracking RMPs for drugs approved in the European Union and explain why it is crucial for sponsors submitting marketing applications to have a thorough knowledge of safety plans already required for similar products.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/HGkhFgYo8vg" height="1" width="1"/&gt;</description><pubDate>Fri, 12 Feb 2010 09:33:12 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/reviewing-existing-risk-management-plans/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/reviewing-existing-risk-management-plans/</feedburner:origLink></item><item><title>Quintiles’ Christopher Ung Discusses the Future of Biomarkers, Digital Pathology and Personalized Medicine in PharmaAsia</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/PFpxY6hr6ok/</link><description>Christopher Ung, Vice President, Strategic Business and Operations, Oncology, recently authored an article on biomarkers, digital pathology and the future of personalized medicine for the&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/PFpxY6hr6ok" height="1" width="1"/&gt;</description><pubDate>Tue, 09 Feb 2010 12:49:30 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/quintiles-christopher-ung-discusses-future-biomarkers-digital-pathology-and-personalized-medicine-pharmaasia/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/quintiles-christopher-ung-discusses-future-biomarkers-digital-pathology-and-personalized-medicine-pharmaasia/</feedburner:origLink></item><item><title>Quintiles Consultant wins National Recognition</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/s1ww4GYepNo/</link><description>Jim Kirk receives PMRG President’s Award at the Fall conference.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/jim-kirk-pmrg-award.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/s1ww4GYepNo" height="1" width="1"/&gt;</description><pubDate>Wed, 18 Nov 2009 16:22:58 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/jim-kirk-pmrg-award/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/jim-kirk-pmrg-award/</feedburner:origLink></item><item><title>Early Phase Optimization Strategies</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/iV-O8YrtC6c/</link><description>As payers balk at rising drug prices and patent expirations threaten the industry’s revenue
streams, pharmaceutical companies worldwide are looking for ways to cut costs associated with
drug development and, simultaneously, speed the process up.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/early-phase-optimization-strategies.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/iV-O8YrtC6c" height="1" width="1"/&gt;</description><pubDate>Wed, 18 Nov 2009 14:15:08 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/early-phase-optimization-strategies/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/early-phase-optimization-strategies/</feedburner:origLink></item><item><title>Sage Bionetworks Announces Donation from Quintiles</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/SyiUiTYEDfI/</link><description>Sage Bionetworks, a not-for-profit organization established to develop an open-access genomic platform for use in drug discovery, announced a major founding donation from Quintiles.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/SyiUiTYEDfI" height="1" width="1"/&gt;</description><pubDate>Wed, 07 Oct 2009 10:26:24 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/sage-bionetworks-announces-donation-quintiles/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/sage-bionetworks-announces-donation-quintiles/</feedburner:origLink></item><item><title>Quintiles CMO to Serve as Keynote Speaker at Local Techwire "Sustainability in Crisis" Event</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/TGE6ang1kLk/</link><description>Quintiles Chief Medical and Scientific Officer Dr. Oren Cohen will serve as the keynote speaker at Local Techwire's Executive Exchange event.  The title of Cohen's presentaiton for the November 12 event in Research Triangle Park, NC will be “Sustainability in Time of Crisis."&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/TGE6ang1kLk" height="1" width="1"/&gt;</description><pubDate>Mon, 05 Oct 2009 11:05:24 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/quintiles-cmo-serve-keynote-speaker-local-techwire-sustainability-crisis-event/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/quintiles-cmo-serve-keynote-speaker-local-techwire-sustainability-crisis-event/</feedburner:origLink></item><item><title>Clinical Educator Teams: Their time has come, and pharma's taking notice</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/0jMtiawHjG0/</link><description>Through educational services, clinical educators can provide a solution to healthcare providers and patients alike when it comes to boosting treatment adoption, compliance and adherence. 


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/clinical-educator-teams-their-time-has-come-and-pharmas-taking-notice.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/0jMtiawHjG0" height="1" width="1"/&gt;</description><pubDate>Mon, 05 Oct 2009 00:00:00 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/clinical-educator-teams-their-time-has-come-and-pharmas-taking-notice/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/clinical-educator-teams-their-time-has-come-and-pharmas-taking-notice/</feedburner:origLink></item><item><title>Patient Outcomes and Health Economics</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/7Z0uPY6onNo/</link><description>Across Europe the impetus to measure patient outcomes and demonstrate positive health economic benefits is intensifying. Jacco Keja, Managing Director and Practice Leader at Quintiles Consulting, visiting Professor Life Sciences Pricing, Erasmus University, looks at the emerging opportunities for pharma companies within this environment.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/patient-outcomes-and-health-economics.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/7Z0uPY6onNo" height="1" width="1"/&gt;</description><pubDate>Fri, 25 Sep 2009 00:00:00 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/patient-outcomes-and-health-economics/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/patient-outcomes-and-health-economics/</feedburner:origLink></item><item><title>The Art of the Possible - A Conversation with Quintiles CIO Bill Deam</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/paWIh3y1zYU/</link><description>WRAL's Local Techwire talks with Quintiles CIO Bill Deam about how the company soared to the # 50 position in the 2009 InformationWeek 500 annual ranking of the nation’s most innovative users of information technology.

Deam calls Quintiles' approach the "Art of the Possible."&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/paWIh3y1zYU" height="1" width="1"/&gt;</description><pubDate>Tue, 15 Sep 2009 15:30:59 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/art-possible-conversation-quintiles-cio-bill-deam/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/art-possible-conversation-quintiles-cio-bill-deam/</feedburner:origLink></item><item><title>Local Techwire Profiles Quintiles' Debut in InformationWeek 500</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/zlzMWHZZcV4/</link><description>WRAL's Local Techwire profiles Quintiles inclusion in the 21st annual InformationWeek 500, the publication’s annual ranking of the nation’s most innovative users of information technology.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/zlzMWHZZcV4" height="1" width="1"/&gt;</description><pubDate>Tue, 15 Sep 2009 15:24:49 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/local-techwire-profiles-quintiles-debut-informationweek-500/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/local-techwire-profiles-quintiles-debut-informationweek-500/</feedburner:origLink></item><item><title>Quintiles' Chief Medical Officer Quoted in CBS News Story on H1N1 Vaccine Development &amp; Distributrion</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/K1r_fwptMM0/</link><description>Quintiles' Chief Medical and Scientific Officer Oren Cohen comments on H1N1 vaccine development and distributrion in a CBS News story.  Cohen tells CBS News that getting vaccinated may be a bit tricky. Quintiles is working on a number of new treatments for influenza.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/K1r_fwptMM0" height="1" width="1"/&gt;</description><pubDate>Wed, 02 Sep 2009 14:00:34 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/oren-cohen-omments-h1n1-cbs-news/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/oren-cohen-omments-h1n1-cbs-news/</feedburner:origLink></item><item><title>Innovex Success At PharmaField Awards Including New Hospital Rep of the Year</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/-HxSEM82OU0/</link><description>Competitions such as the one run by PharmaField help us to showcase our talent and demonstrate that we have many of the best and brightest in the business.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/-HxSEM82OU0" height="1" width="1"/&gt;</description><pubDate>Fri, 14 Aug 2009 14:23:19 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/innovex-success-pharmafield-awards-including-new-hospital-rep-year/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/innovex-success-pharmafield-awards-including-new-hospital-rep-year/</feedburner:origLink></item><item><title>Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/bLOLbA9ROQU/</link><description>The project pooled blinded data from existing completed clinical trials contributed by Eli Lilly and Company, GlaxoSmithKline, Hoffmann-LaRoche, Inc, and Merck Research Laboratories into a single database hosted by Quintiles Transnational Corporation.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/bLOLbA9ROQU" height="1" width="1"/&gt;</description><pubDate>Mon, 29 Jun 2009 15:53:16 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/utility-adiponectin-biomarker-predictive-glycemic-efficacy/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/utility-adiponectin-biomarker-predictive-glycemic-efficacy/</feedburner:origLink></item><item><title>Should Venture Firms Bundle Their Biotech Portfolios?</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/jGZl5ik3kl8/</link><description>Ron Wooten, president of NovaQuest, an investment and business-development unit of Quintiles Transnational Corp., a contract-research organization, thinks so.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/jGZl5ik3kl8" height="1" width="1"/&gt;</description><pubDate>Mon, 29 Jun 2009 10:18:43 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/should-venture-firms-bundle-their-biotech-portfolios/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/should-venture-firms-bundle-their-biotech-portfolios/</feedburner:origLink></item><item><title>Hungary Best Employers News Coverage</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/Dkv3OuKoJc0/</link><description>Taroltak a magyarok.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/taroltak-a-magyarok.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/Dkv3OuKoJc0" height="1" width="1"/&gt;</description><pubDate>Tue, 16 Jun 2009 11:27:20 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/taroltak-a-magyarok/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/taroltak-a-magyarok/</feedburner:origLink></item><item><title>With so many CROs out there, which one is the best?</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/--1n_C0fvKA/</link><description>PharmaceuticalJobSite.com decided "to try and determine which is the best CRO....we have decided on which CRO we feel has the best overall reputation."&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/--1n_C0fvKA" height="1" width="1"/&gt;</description><pubDate>Fri, 05 Jun 2009 10:35:56 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/so-many-cros-which-one-best/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/so-many-cros-which-one-best/</feedburner:origLink></item><item><title>Dennis Gillings Discusses Strategy with WRAL</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/w_vpmAAyMVU/</link><description>Quintiles Chairman and CEO, Dennis Gillings, CBE, discussed long-term and short-term strategy with CBS television affiliate WRAL as part of the NC CEO FORUM on May 15, 2009.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/w_vpmAAyMVU" height="1" width="1"/&gt;</description><pubDate>Mon, 18 May 2009 10:53:42 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/dennis-gillings-discusses-strategy-wral/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/dennis-gillings-discusses-strategy-wral/</feedburner:origLink></item><item><title>Dr. McKee Comments on Vaccine Development</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/SpR2Jv-nT04/</link><description>Quintiles expert Kelly McKee, MD tapped for insight on flu vaccine development.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/SpR2Jv-nT04" height="1" width="1"/&gt;</description><pubDate>Fri, 15 May 2009 11:28:10 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/dr-mckee-comments-vaccine-development/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/dr-mckee-comments-vaccine-development/</feedburner:origLink></item><item><title>Dr. Cohen Delivers Advice on Swine Flu</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/GM-nBy6JtDI/</link><description>Quintiles infectious disease expert tapped for insight on H1N1 virus (swine flu) outbreak.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/GM-nBy6JtDI" height="1" width="1"/&gt;</description><pubDate>Thu, 07 May 2009 14:01:41 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/dr-cohen-delivers-advice-swine-flu/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/dr-cohen-delivers-advice-swine-flu/</feedburner:origLink></item><item><title>Boosting Adherence Patient Outcomes and Market Access with Patient-centric Strategies for Pharma</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/5p0Iknm2vNI/</link><description>Patient-centric programs and strategies can deliver improved market access, patient compliance and patient outcomes, according to a panel of industry experts assembled at a recent webinar, Patient-centric Strategies for European Pharma, organized by eyeforpharma in partnership with Innovex.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/5p0Iknm2vNI" height="1" width="1"/&gt;</description><pubDate>Fri, 27 Mar 2009 09:05:35 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/boosting-adherence-patient-outcomes/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/boosting-adherence-patient-outcomes/</feedburner:origLink></item><item><title>New Quintiles HQ Stands Out</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/bL9SODO7-Ek/</link><description>Quintiles' revenue was up about 50 percent last year compared with 2003.&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/bL9SODO7-Ek" height="1" width="1"/&gt;</description><pubDate>Thu, 26 Mar 2009 12:15:43 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/new-quintiles-hq-stands-out/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/new-quintiles-hq-stands-out/</feedburner:origLink></item><item><title>Joining Forces</title><link>http://feedproxy.google.com/~r/QuintilesInTheNews/~3/n7QNgA6-dtY/</link><description>Global partnership enable big pharma to streamline drug development and refocus their efforts on core competencies.


   &lt;a href="http://www.quintiles.com/elements/media/inthenews/NQFAJoiningForces.pdf"&gt;Download the PDF&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/QuintilesInTheNews/~4/n7QNgA6-dtY" height="1" width="1"/&gt;</description><pubDate>Thu, 19 Mar 2009 11:53:21 -0400</pubDate><guid isPermaLink="false">http://www.quintiles.com/information-library/in-the-news/joining-force/</guid><feedburner:origLink>http://www.quintiles.com/information-library/in-the-news/joining-force/</feedburner:origLink></item></channel></rss>
